Human Formulations

Silodosin 8 mg + Dutasteride 0.5 mg Capsules (Each Hard Gelatin Capsules)

Silodosin 8 mg + Dutasteride 0.5 mg Capsules (Each Hard Gelatin Capsules) is a hard gelatin capsule formulated with Silodosin 8 mg + Dutasteride 0.5 mg (Each ). The listed active ingredient profile is Silodosin; Dutasteride, placing the product in the uro

CapsulesNon-Beta-Lactam Capsules Single Ingredient Hard Gelatin Capsule
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Capsules, Non-Beta-Lactam Capsules
Dosage Form
Hard Gelatin Capsule
Product Type
Single Ingredient

Available strengths

Silodosin 8 mg + Dutasteride 0.5 mg (Each )

Description

Silodosin 8 mg + Dutasteride 0.5 mg Capsules (Each Hard Gelatin Capsules) is a hard gelatin capsule formulated with Silodosin 8 mg + Dutasteride 0.5 mg (Each ). The listed active ingredient profile is Silodosin; Dutasteride, placing the product in the urology category. The formulation contains medicine(s) used in selected lower-urinary-tract or prostate-related conditions. The source identifies the dosage form as hard gelatin capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured